Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

GNRHR antibody (N-Term)

GNRHR Reactivity: Human IF, FACS Host: Mouse Monoclonal A9E4 unconjugated
Catalog No. ABIN6163408
  • Target See all GNRHR Antibodies
    GNRHR (Gonadotropin-Releasing Hormone Receptor (GNRHR))
    Binding Specificity
    • 24
    • 24
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-29, N-Term
    Reactivity
    • 57
    • 15
    • 14
    • 2
    • 1
    Human
    Host
    • 31
    • 27
    • 1
    Mouse
    Clonality
    • 31
    • 28
    Monoclonal
    Conjugate
    • 32
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This GNRHR antibody is un-conjugated
    Application
    • 26
    • 25
    • 24
    • 20
    • 9
    • 8
    • 7
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (IF), Flow Cytometry (FACS)
    Purpose
    Mouse Monoclonal anti-GnRH Receptor (LHRH Receptor) (A9E4), Purified, BSA-free
    Characteristics
    This antibody recognizes an epitope on the extracellular domain of gonadotropin releasing hormone (GnRH) receptor or luteinizing hormone receptor (LHCGR). Lutropin (also designated luteinizing hormone) plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Gonadotropin (also designated choriogonadotropin) production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor. GnRH receptor contains seven hydrophobic transmembrane domains connected by hydrophilic extracellular and intracellular loops characteristic of G-protein coupled receptors. GnRH stimulates the gonadotrophs of the anterior pituitary to secrete luteinizing hormone (LH) as well as follicle-stimulating hormone (FSH). GnRH influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of GnRH on breast carcinoma correlates in part to the degree of tumor differentiation. GnRH-positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. GnRH is present in luteal and granulosa cells as well as in ovarian cell membrane preparations. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
    Purification
    Purified
    Immunogen
    A synthetic peptide aa 1-29 (MANSASPEQNQHCSAINNSIPLMQGNLPY) from the N-terminal of human GnRH receptor.
    Clone
    A9E4
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product GNRHR Primary Antibody
  • Application Notes
    Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Predicted to react with pig or rabbit, others not known
    • Optimal dilution for a specific application should be determined by user
    Comment

    T47D cells. Pituitary gland, ovarian or breast cancers.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS (no BSA, no azide)
    Preservative
    Azide free
  • Target
    GNRHR (Gonadotropin-Releasing Hormone Receptor (GNRHR))
    Alternative Name
    GnRH Receptor (LHRH Receptor) (GNRHR Products)
    Molecular Weight
    54-60 kDa
You are here:
Support